Protagonist Therapeutics (PTGX.Q) announced the receipt of verbal communication from the U.S. Food and Drug Administration (FDA) that the Company’s clinical studies for rusfertide have been placed on a…
September 17, 2021
Innate Pharma S.A. (IPHA.Q) announced today that AstraZeneca has presented results from the randomized COAST Phase 2 trial during the European Society for Medical Oncology (ESMO) Congress 2021 on…
The eternal question of how to make money in the stock market has never been more important. With interest rates in the toilet, leaving your hard-earned dollars in a…
Week in Review (Week 5) Change is inevitable. As someone who is terrified of change, that’s a hard pill to swallow. In fact, if you told me that the…
The rapid increase in the popularity of the E-sports industry is a best-case scenario of the integration between traditional entertainment and the new age of digital media. Although the…
One of our macro outlooks for being bullish the agriculture sector has been a food crisis. Supply chain issues. It seems the signs are upon us! The story recently…
Because we’re all about value let’s start this out with some fake news. Walmart (WMT.NYSE) decidedly did not partner with Litecoin, despite news published earlier this week that…
Diverse clinics Ketamine One (MEDI.NE) announced it’s adding 2 more locations to its already bustling ketamine clinic network. Through an acquisition last week, Ketamine One gains control of Illumma…